 Home > Medical News > Latest Medical News > Xinlitai hypertension drug allisartan medoxomil and indapamide sustained-release tablets received clinical approval

Xinlitai hypertension drug allisartan medoxomil and indapamide sustained-release tablets received clinical approval

 Last Update: 2021-06-17
 Source: Internet
 Author: User

Tags

clinical advisor

ind clinical trial

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Today, Xinlitai issued an announcement stating that the company received the "Clinical Trial Approval Notice" approved and issued by the National Medical Products Administration, and agreed to carry out clinical trials for allisartan medoxomil indapamide sustained-release tablets
.

Allisartan medoxomil and indapamide sustained-release tablets (project code: SAL0108) are ARB/diuretic compound preparations, and the intended development indication is antihypertensive
.

After the product is launched, it will form a strategic synergy with the company's listed 1.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.